What do Analysts Say about: CVS Health Corporation (NYSE:CVS)


CVS Health Corporation (NYSE:CVS) will report its next earnings on Feb 7 – Feb 13 (Est.). The company reported the earnings of $1.64/Share in the last quarter where the estimated EPS by analysts was $1.57/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 4.5%.

Many analysts are providing their Estimated Earnings analysis for CVS Health Corporation and for the current quarter 21 analysts have projected that the stock could give an Average Earnings estimate of $1.68/share. These analysts have also projected a Low Estimate of $1.64/share and a High Estimate of $1.8/share.

In case of Revenue Estimates, 19 analysts have provided their consensus Average Revenue Estimates for CVS Health Corporation as 46.49 Billion. According to these analysts, the Low Revenue Estimate for CVS Health Corporation is 45.83 Billion and the High Revenue Estimate is 47.61 Billion. The company had Year Ago Sales of 41.14 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for CVS to be 9.8%. They are projecting Next Quarter growth of 4.2%. For the next 5 years, CVS Health Corporation is expecting Growth of 11.18% per annum, whereas in the past 5 years the growth was 14.63% per annum.

Some buy side analysts are also providing their Analysis on CVS Health Corporation, where 8 analysts have rated the stock as Strong buy, 11 analysts have given a Buy signal, 5 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 22 Analysts reported that the Price Target for CVS Health Corporation might touch $115 high while the Average Price Target and Low price Target is $88.02 and $66.9 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. CVS Health Corporation got Downgrade on 20-Jun-16 where investment firm Morgan Stanley Downgrade the stock from Overweight to Equal-Weight.

CVS Health Corporation closed its last trading session at $74.78 with the gain of 1.47%. The Market Capitalization of the company stands at 80.92 Billion. The Company has 52-week high of $106.67 and 52-week low of $69.3. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.8% where SMA50 and SMA200 are -9.1% and -19.05% respectively. The Company Touched its 52-Week High on May 9, 2016 and 52-Week Low on Nov 8, 2016.

The Relative Volume of the company is 1.14 and Average Volume (3 months) is 7.56 million. CVS Health Corporation P/E (price to earnings) ratio is 16.19 and Forward P/E ratio of 12.73.

The company shows its Return on Assets (ROA) value of 5.1%. The Return on Equity (ROE) value stands at 13.2%. While it’s Return on Investment (ROI) value is 9.4%.

While looking at the Stock’s Performance, CVS Health Corporation currently shows a Weekly Performance of 2.26%, where Monthly Performance is -8.97%, Quarterly performance is -17.82%, 6 Months performance is -20.7% and yearly performance percentage is -17.9%. Year to Date performance value (YTD perf) value is -20.99%. The Stock currently has a Weekly Volatility of 1.52% and Monthly Volatility of 2.23%.